ArticleScience China. Life sciences2024

Self-adjuvant Astragalus polysaccharide-based nanovaccines for enhanced tumor immunotherapy: a novel delivery system candidate for tumor vaccines.

Nan Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.